InvestorsHub Logo
Followers 85
Posts 1581
Boards Moderated 0
Alias Born 06/06/2012

Re: scottsmith post# 183633

Tuesday, 05/30/2017 10:59:29 AM

Tuesday, May 30, 2017 10:59:29 AM

Post# of 403618
Yes 50m would be nice but J and J paying more once Drug gets to Phase 2b--likely where we'd be at pending newer formulations.

//

Protagonist $125 million if it moves the drug into phase 2b and a further $200 million if it sticks with the asset after getting a look at data from the trial.